Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
94514 trials found · Page 132 of 4726
-
New mRNA shingles vaccine enters phase 2 trial
⭐️ VACCINE ⭐️ Not yet recruitingThe study will evaluate the safety, tolerability, and immunogenicity (your immune system's reaction) of 3 dose levels of the study vaccine called Herpes Zoster IN001 mRNA Vaccine (IN001) in healthy participants who are between 50 and 79 years of age.
Phase: PHASE2 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:02 UTC
-
Computer guidance may sharpen liver cancer treatment
Disease control Recruiting nowThe goal of this clinical trial is to learn if the intraoperative use of a computer guidance software can improve the success of liver tumor ablation in adults. The employed software calculates and displays a simulation of the ablation such that the physician can visualize what p…
Phase: NA • Sponsor: NE Scientific INC • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Fat infusion showdown: can a better oil save preemie lungs and brains?
Disease control Recruiting nowThe purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New study aims to save organs in stomach cancer patients
Disease control Not yet recruitingThis study will test a new personalized treatment approach for patients with stomach or esophageal cancer. It will take place in two stages and aims to find the best combination of chemotherapy, immunotherapy, and targeted drugs based on each patient's tumor biomarkers. Upon enr…
Phase: PHASE2 • Sponsor: American Association for Cancer Research • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New combo therapy aims to wipe out breast tumors before surgery
Disease control Recruiting nowThis is an prospective, open label, multicenter study to evaluate the efficacy and safety of neoadjuvant Iparomlimab and Tuvonralimab (QL1706) in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 15, 2026 08:54 UTC
-
New hope for aggressive brain tumors: experimental combo targets first recurrence
Disease control Not yet recruitingApproximately 58-68 total subjects will be enrolled. In the first stage, 10 response evaluable subjects (either IDHwt or IDHm Grade 4 astrocytoma) will be enrolled. If 1 or more of the first 10 response evaluable subjects achieve an objective response, 19 further subjects may be …
Phase: PHASE1, PHASE2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Simple hormone pill may stop dangerous pregnancy condition
Prevention Not yet recruitingThis randomized controlled trial evaluates whether nightly vaginal micronized progesterone (400 mg) initiated before 12 weeks' gestation reduces the incidence of preeclampsia in low-risk pregnant individuals. Participants will be randomly assigned (1:1) to receive either vaginal …
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Prevention
Last updated May 15, 2026 08:53 UTC
-
New drug cocktail aims to boost stroke recovery
Disease control Not yet recruitingThis study is a multicentre, randomized, blinded-endpoint trial that aims to evaluate the efficacy and safety of human urinary kallidinogenase combined with reteplase intravenous thrombolysis in the treatment of acute ischemic stroke
Phase: NA • Sponsor: China-Japan Union Hospital • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Nasal spray during labor may ward off postpartum depression
Prevention Not yet recruitingBrief Title: Intranasal Dexmedetomidine for Postpartum Depression Prevention: A Randomized Trial This study aims to evaluate the effect of intranasal dexmedetomidine (Dex) administered before combined spinal-epidural labor analgesia on the incidence of postpartum depression (PPD)…
Phase: NA • Sponsor: Chengdu Jinjiang Maternity and Child Health Hospital • Aim: Prevention
Last updated May 13, 2026 16:03 UTC
-
New triple therapy offers hope for advanced lung cancer patients who failed first treatment
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate progression-free survival (PFS) of microwave ablation in combination with tislelizumab and docetaxel in patients with advanced non-small cell lung cancer (NSCLC) who have progressed following first-line immunotherapy combined with…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New hope for bile duct cancer: drug combo aims to extend life
Disease control Not yet recruitingThe object of this trial is to evaluate the efficacy of D07001-softgel capsules + capecitabine compared with placebo + capecitabine by overall survival (OS). Eligible patients with advanced biliary tract cancer (BTC) will be randomized (1:1:1) to receive either 60 mg D07001-soft…
Phase: PHASE3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated May 15, 2026 08:56 UTC
-
Could a simple blood injection repair womb damage and boost baby chances?
Disease control Not yet recruitingIntrauterine adhesions (IUA) caused by endometrial basal layer injury can lead to reduced menstrual flow, infertility, recurrent pregnancy loss, and poor reproductive outcomes. Hysteroscopic adhesiolysis with uterine cavity reconstruction is the standard treatment, but women with…
Phase: NA • Sponsor: Beijing Obstetrics and Gynecology Hospital • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Simple blood test could spot pancreatic cancer sooner
Diagnosis Not yet recruitingThe purpose of this research study is to test a new process for diagnosing pancreatic cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this st…
Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated May 15, 2026 08:56 UTC
-
Dental screening before heart valve surgery may save lives
Prevention Not yet recruitingThis randomized, multicenter, open-label trial evaluates whether preoperative dental screening improves outcomes in patients undergoing surgical or transcatheter cardiac valve intervention. Participants are randomized 1:1 to preoperative dental screening or no screening. The prim…
Phase: NA • Sponsor: Region Skane • Aim: Prevention
Last updated May 15, 2026 08:55 UTC
-
Shorter radiation plus immunotherapy may improve rectal cancer outcomes
Disease control Not yet recruitingIn this prospective, multicentre, randomized phase III trial, 612 locally advanced rectal cancer (LARC, T3-4/N+M0) patients with at least one high-risk features (lower location (≤5cm), cT4, cN2, MRF+, EMVI+, TD+) will be included, and randomly assigned to TNT group and iTNT group…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New hope for bulky lung cancer: drug plus chemoradiation may slow tumor growth
Disease control Not yet recruitingThis is a randomized, controlled, multicenter clinical study that enrolled patients with unresectable bulky stage III NSCLC, with PFS as the primary endpoint. The study aims to investigate the efficacy and safety of adebrelimab combined with chemoradiotherapy in the treatment of …
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 15, 2026 08:56 UTC
-
New drug duo aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis phase II trial tests how well nemtabrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Nemtabrutinib is in a class of medications called kinase inhibitors. It blocks a protein called BTK, which is pre…
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug cocktail aims to crush leukemia in newly diagnosed patients
Disease control Recruiting nowThis is a phase II, open-label, multi-center study evaluating the efficacy and safety of sonrotoclax (SA) in combination with azacitidine (AZA) plus individualized targeted or chemotherapeutic agents in adult participants with newly diagnosed acute myeloid leukemia (AML). Eligibl…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 15, 2026 08:54 UTC
-
Triple therapy aims to turn inoperable lung cancer into a surgical target
Disease control Not yet recruitingThe goal of this phase 2 trial is to evaluate the efficacy and safety of tislelizumab combined with intravenous chemotherapy and bronchial artery chemoembolization (BACE) as conversion therapy for patients with initially unresectable stage IIIA-IIIB non-small cell lung cancer (NS…
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Arm cuff therapy could protect heart and brain after stroke
Disease control Not yet recruitingIntroduction: The management of acute myocardial injury following acute ischemic stroke (AMI-AIS), a frequent complication that severely worsens prognosis, is challenging. Remote ischemic conditioning (RIC) has demonstrated therapeutic potential in separate cardiac and cerebrovas…
Phase: PHASE3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated May 15, 2026 08:56 UTC